Lifecare has now placed the purchase order for automated production software.
Reference is made to Lifecare’s list of trigger events, as presented at the semi-annual report of August 20th 2023 and later investor communication. The launch of an automated production line by end of Q2 2024 is set as a major milestone. To accomplish this, the company has decided on the preferred partner and supplier of essential production machines and concluded to apply customized Scanning Electron Microscopes from Carl Zeiss IQS Deutschland GmbH (Zeiss) as the best cornerstone equipment for the upcoming automated production.
The software order to Zeiss for automated production software is the result of longer negotiations for clarification of overall customization and adaptation potentials. Following the delivery, the Lifecare NanoBioSensors team in Reutlingen Germany will initiate the customization efforts for the final automated production of Lifecare Sencell sensors. Automated pilot production is initially planned with the Scanning Electron Microscopes of Naturwissenschaftliches und Medizinisches Institut (“NMI”) at the University of Tübingen Germany, to which Lifecare has access through an existing cooperation agreement.
Negotiations with Zeiss are further proceeding to finalize the specification, price and lead time of the Scanning Electron Microscopes is expected to be finalized in Q4 2023 for the purchase of hardware. The timeline allows for launch of the automated production line and entry to veterinary market by end of Q2 2024.